Finance

Lists
Why is 4119 down 2,88%?
Dive Deeper
4119:TPE
SCI Pharmtech Inc
NT$48,85
-2,88%
(-1,45) 1D
16 Nov., 13:30:18 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 4119...
Open
NT$50,00
High
NT$50,60
Low
NT$48,85
Mkt. cap
5,84 mjd
Avg. vol.
129,39 k
Volume
106,14 k
Dividend
1,54%
Quarterly dividend
NT$0,19
Ex-dividend date
01 Jul. 2026
P/E ratio
97,46
52-wk high
NT$60,70
52-wk low
NT$39,60
EPS
NT$0,50
Shares outstanding
79,48 m
No. of employees
241
Open
NT$50,00
High
NT$50,60
Low
NT$48,85
Mkt. cap
5,84 mjd
Avg. vol.
129,39 k
Volume
106,14 k
Dividend
1,54%
Quarterly dividend
NT$0,19
Ex-dividend date
01 Jul. 2026
P/E ratio
97,46
52-wk high
NT$60,70
52-wk low
NT$39,60
EPS
NT$0,50
Shares outstanding
79,48 m
No. of employees
241
News stories
From web sources and news partners
About SCI Pharmtech Inc
CEO-
Employees241
Founded1987
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
Des. 2025
Mrt. 2026
Jun. 2026
Sep. 2026
Revenue
355,47 m
375,80 m
272,86 m
503,14 m
Cost of goods sold
255,88 m
293,47 m
218,00 m
374,16 m
Cost of revenue
255,88 m
293,47 m
218,00 m
374,16 m
Research and development expenses
9,82 m
9,10 m
10,12 m
9,28 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
46,98 m
40,07 m
35,42 m
52,16 m
Operating expense
56,80 m
49,17 m
45,53 m
61,44 m
Total operating expenses
312,67 m
342,65 m
263,53 m
435,61 m
Operating income
42,80 m
33,15 m
9,34 m
67,54 m
Other non operating income
4,19 m
5,32 m
2,52 m
254,00 k
EBT including unusual items
42,28 m
28,59 m
-12,60 m
56,37 m
EBT excluding unusual items
42,23 m
28,56 m
-12,60 m
56,37 m
Income tax expense
3,42 m
8,48 m
248,00 k
12,63 m
Effective tax rate
8,10%
29,66%
-1,97%
22,40%
Other operating expenses
-
-
-
-
Net income
38,86 m
20,11 m
-12,85 m
43,74 m
Net profit margin
10,93%
5,35%
-4,71%
8,69%
Earnings per share
-
-
-
-
Interest and investment income
578,00 k
1,00 k
359,00 k
-
Interest expense
-1,81 m
-2,08 m
-2,51 m
-5,44 m
Net interest expenses
-1,23 m
-2,08 m
-2,15 m
-5,44 m
Depreciation and amortization charges
-
-
-
-
EBITDA
104,97 m
95,55 m
72,04 m
162,20 m
Gain or loss from assets sale
-
-
-
2,87 m
Upcoming events
AI content may include mistakes. Learn more
Google-programme